• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Pneumococcal Vaccine Aids Young and Elderly Alike

Article

Hospitalizations for to pneumococcal disease have been reduced since the introduction of the 7-valent vaccine (PCV7). The PCV7 vaccine has no only helped children, but the elderly as well.

Hospitalizations for to pneumococcal disease have been reduced since the introduction of the 7-valent vaccine (PCV7). The PCV7 vaccine has no only helped children, but the elderly as well. Contemporary Pediatrics reports:

In the 10 years following the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), hospitalizations for pneumococcal disease have been and remain drastically reduced, not just for children but also for adults and particularly for the elderly, according to a new report.

Using a nationwide inpatient sample database, researchers from Vanderbilt University and the Centers for Disease Control and Prevention (CDC) looked at rates of pneumonia-related hospitalizations during the periods 1997 to 1999, before the introduction of the vaccine, and 2007 to 2009, well after the introduction of PCV7 in 2000, but before the switch to 13-valent pneumococcal conjugate vaccine (PCV13) in 2010.

Overall, in all age groups, the investigators calculated a 10.5% reduction in hospitalizations for pneumonia.

Read the full story: http://bit.ly/1dELpOw

Related Videos
Yael Mauer, MD, MPH
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Amit Singal, MD, UT Southwestern Medical Center
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Rashon Lane, PhD, MA
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Beau Raymond, MD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.